Mode
Text Size
Log in / Sign up
N/A N=25 Treatment

Catheter Placement for Hepatic Hydrothorax

Pleural Effusion

Enrolled (actual)
25
Serious AEs
0.0%
Results posted
May 2018
Primary outcome: Primary: Feasibility of Using Indwelling Tunneled Pleural Catheters for the Management of Hepatic Hydrothorax — 25 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Indwelling tunneled pleural catheter (ITPC) (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Washington University School of Medicine
Primary completion
Jul 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility of Using Indwelling Tunneled Pleural Catheters for the Management of Hepatic Hydrothorax
25

Summary

The purpose of this study is to evaluate the effectiveness of an indwelling tunneled pleural catheter (ITPC) in the management of hepatic hydrothorax that is not responsive to conventional medical therapy. Hepatic Hydrothorax (HH) is defined as an accumulation of fluid in the pleural space between the chest wall and the lung and occurs in 5-10% of patients with liver disease. Despite medical therapy with diuretics and salt restriction, many patients still experience intractable, debilitating shortness of breath, often necessitating hospital admission. Repeated thoracentesis,which is a procedure in which the hepatic hydrothorax is drained with a needle may be effective, but is often only temporary prior to the reaccumulation of fluid leading to the requirement of repeated procedures. Trans-jugular intrahepatic porto-systemic shunt (TIPS), while a valuable treatment for HH, is not always effective or able to be performed. Similarly, liver transplantation although potentially curative, is not available to many patients and may be significantly delayed. Many patients do not experience sufficient or timely relief with current conventional therapy.

Eligibility Criteria

Inclusion Criteria

  • Subjects who have recurrent pleural effusion due to underlying cirrhosis
  • Subjects who are potential candidates for liver transplantation
  • Subjects who are candidates for transjugular intrahepatic portosystemic shunt procedures
  • Subjects who have had at least one thoracentesis in the past three months

Exclusion Criteria

  • Subjects with active bacterial or fungal infection
  • Subjectswho are not potential candidates for transplantation
  • Subjects with pleural effusions due to processes other than cirrhosis
  • Subjects who are critically ill at the time of referral, requiring intensive care unit admission
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02595567). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search